STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation

BACKGROUND: Upregulation of Stathmin 1 (STMN1), a cytoplasmic phosphoprotein that controls the dynamics of cellular microtubules, is linked to malignant behavior and poor prognosis in a range of malignancies. However, little research has been done on STMN1’s potential role in HCC as a single factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, En-di, Li, Chenxuan, Fang, Yuan, Li, Na, Xiao, Zhongyun, Chen, Chuhong, Wei, Benkai, Wang, Hangping, Xie, Jincheng, Miao, Yinglei, Zeng, Zhong, Huang, Hanfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487063/
https://www.ncbi.nlm.nih.gov/pubmed/36127700
http://dx.doi.org/10.1186/s12957-022-02768-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487063/
https://www.ncbi.nlm.nih.gov/pubmed/36127700
http://dx.doi.org/10.1186/s12957-022-02768-y

Ejemplares similares